Clinical Trials in Pittsburgh

Showing 3421-3440 of 21,047 trials

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

NCT06468202

The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertensive disorders of pregnancy (HDP), and that there are multiple factors associated with adherence with aspirin therapy that will be important to identify to enable optimal implementation of study findings and population-level benefits.

Hypertensive Disorders of PregnancyPreeclampsiaGestational Hypertension

Ohio State University10,742 participantsStarted Oct 2024

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +13 more locations

RECRUITING< 1 mile

Stroke Thrombectomy and Aneurysm Registry

NCT04994756

This international multi-center registry is used to collect existing information and outcomes for patients undergoing an operation for treatment of injuries to the brain including the blockage of blood flow to an area of the brain, an abnormal ballooning of an artery, abnormal tangling of blood vessels, abnormal formation of blood vessels, tearing of vein, and bleeding in the brain. This information is used to help predict outcomes that undergo an operation for treatment of the above-listed brain injuries. Additionally, the information is used to compare techniques and devices' effects on technical and clinical outcomes.

StrokeThromboses, IntracranialAneurysm, Brain

Medical University of South Carolina40,000 participantsStarted Sep 2019

Birmingham, Alabama, United States • Loma Linda, California, United States • Santa Barbara, California, United States +60 more locations

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Stroke Thrombectomy and Aneurysm Registry

Find Trials by Condition in Pittsburgh

CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

A Prospective Non-concurrent Controlled Evaluation of Open and MAS® PLIF

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

SP Thoracic IDE Study

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

A Study of YL242 in Subjects With Advanced Solid Tumors